Light Horse Therapeutics (Series A)

Funding Details
Awarder
Inbox
Date Award
May 19, 2025
Vertical
Biotech / Medtech
Funding URL
View Funding Page

Company Info
Founders
Markus Renschler, Thomas Daniel, Laure Escoubet, Brian Liau, Ben Cravatt, Nathanael Gray
Company Description
Light Horse Therapeutics is a developer of small molecule therapeutics that utilizes a proprietary platform to uncover novel functional sites in disease-critical targets. The company employs precision genetic editing to interrogate proteins in their native environment, enhancing the discovery of clinical candidates.
Market
Therapeutics
Location
San Diego, California, USA
Coinvestors
Versant Ventures, Mubadala Capital, Bristol-Myers Squibb Co, Taiho Ventures, AbbVie

Links
Back to Home Back to Biotech / Medtech Deals View Funding Announcement